{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:11Z","timestamp":1791928691717,"version":"4.3.4"},"reference-count":38,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,7,10]]},"DOI":"10.1167\/iovs.18-24013","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T18:03:07Z","timestamp":1532109787000},"page":"3375","source":"Crossref","is-referenced-by-count":53,"title":["0.005% Preservative-Free Latanoprost Induces Dry Eye-Like Ocular Surface Damage via Promotion of Inflammation in Mice"],"prefix":"10.1167","volume":"59","author":[{"given":"Yiran","family":"Yang","sequence":"first","affiliation":[{"name":"Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Huang","sequence":"additional","affiliation":[{"name":"Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lin","sequence":"additional","affiliation":[{"name":"Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[{"name":"Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Tang","sequence":"additional","affiliation":[{"name":"Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihao","family":"Ye","sequence":"additional","affiliation":[{"name":"Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Xiamen Eye Center of Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, Xiamen, Fujian, China"},{"name":"Xiamen Eye Center of Xiamen University, Xiamen, Fujian, China"},{"name":"Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, Xiamen, Fujian, China"},{"name":"Xiamen Eye Center of Xiamen University, Xiamen, Fujian, China"},{"name":"Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuguo","family":"Liu","sequence":"additional","affiliation":[{"name":"Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, Xiamen, Fujian, China"},{"name":"Xiamen Eye Center of Xiamen University, Xiamen, Fujian, China"},{"name":"Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-8-3375-b01","doi-asserted-by":"crossref","unstructured":"Kong X, Chen Y, Chen X, Sun X. Influence of family history as a risk factor on primary angle closure and primary open angle glaucoma in a Chinese population. Ophthalmic Epidemiol. 2011; 18: 226\u2013232.","DOI":"10.3109\/09286586.2011.595040"},{"key":"i1552-5783-59-8-3375-b02","unstructured":"Lee AJ, McCluskey P. Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol. 2010; 4: 741\u2013764."},{"key":"i1552-5783-59-8-3375-b03","unstructured":"Alm A. Latanoprost in the treatment of glaucoma. Clin Ophthalmol 2014; 8: 1967\u20131985."},{"key":"i1552-5783-59-8-3375-b04","doi-asserted-by":"crossref","unstructured":"Hollo G. The side effects of the prostaglandin analogues. Expert Opin Drug Saf. 2007; 6: 45\u201352.","DOI":"10.1517\/14740338.6.1.45"},{"key":"i1552-5783-59-8-3375-b05","doi-asserted-by":"crossref","unstructured":"Chen W, Dong N, Huang C, et al. Corneal alterations induced by topical application of commercial latanoprost, travoprost and bimatoprost in rabbit. PLoS One. 2014; 9: e89205.","DOI":"10.1371\/journal.pone.0089205"},{"key":"i1552-5783-59-8-3375-b06","doi-asserted-by":"crossref","unstructured":"Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005; 46: 2444\u20132450.","DOI":"10.1167\/iovs.04-1331"},{"key":"i1552-5783-59-8-3375-b07","doi-asserted-by":"crossref","unstructured":"Baudouin C, Liang H, Hamard P, et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology. 2008; 115: 109\u2013115.","DOI":"10.1016\/j.ophtha.2007.01.036"},{"key":"i1552-5783-59-8-3375-b08","doi-asserted-by":"crossref","unstructured":"Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010; 29: 312\u2013334.","DOI":"10.1016\/j.preteyeres.2010.03.001"},{"key":"i1552-5783-59-8-3375-b09","unstructured":"Funke S, Beck S, Lorenz K, et al. Analysis of the effects of preservative-free tafluprost on the tear proteome. Am J Transl Res. 2016; 8: 4025\u20134039."},{"key":"i1552-5783-59-8-3375-b10","doi-asserted-by":"crossref","unstructured":"Uusitalo H, Chen E, Pfeiffer N, et al. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication. Acta Ophthalmol. 2010; 88: 329\u2013336.","DOI":"10.1111\/j.1755-3768.2010.01907.x"},{"key":"i1552-5783-59-8-3375-b11","doi-asserted-by":"crossref","unstructured":"Guglielminetti E, Barabino S, Monaco M, Mantero S, Rolando M. HLA-DR expression in conjunctival cells after latanoprost. J Ocul Pharmacol Ther. 2002; 18: 1\u20139.","DOI":"10.1089\/108076802317233162"},{"key":"i1552-5783-59-8-3375-b12","doi-asserted-by":"crossref","unstructured":"Nakagawa S, Usui T, Yokoo S, et al. Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets. Invest Ophthalmol Vis Sci. 2012; 53: 5154\u20135160.","DOI":"10.1167\/iovs.12-9685"},{"key":"i1552-5783-59-8-3375-b13","doi-asserted-by":"crossref","unstructured":"Pisella PJ, Debbasch C, Hamard P, et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci. 2004; 45: 1360\u20131368.","DOI":"10.1167\/iovs.03-1067"},{"key":"i1552-5783-59-8-3375-b14","doi-asserted-by":"crossref","unstructured":"Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005; 46: 4594\u20134599.","DOI":"10.1167\/iovs.05-0776"},{"key":"i1552-5783-59-8-3375-b15","doi-asserted-by":"crossref","unstructured":"Corrales RM, Stern ME, De Paiva CS, Welch J, Li DQ, Pflugfelder SC. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Invest Ophthalmol Vis Sci. 2006; 47: 3293\u20133302.","DOI":"10.1167\/iovs.05-1382"},{"key":"i1552-5783-59-8-3375-b16","doi-asserted-by":"crossref","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017; 15: 438\u2013510.","DOI":"10.1016\/j.jtos.2017.05.011"},{"key":"i1552-5783-59-8-3375-b17","doi-asserted-by":"crossref","unstructured":"Sharif NA, Kelly CR, Crider JY. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor. J Ocul Pharmacol Ther. 2002; 18: 313\u2013324.","DOI":"10.1089\/10807680260218489"},{"key":"i1552-5783-59-8-3375-b18","doi-asserted-by":"crossref","unstructured":"Ye RD. Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J Leukoc Biol. 2001; 70: 839\u2013848.","DOI":"10.1189\/jlb.70.6.839"},{"key":"i1552-5783-59-8-3375-b19","doi-asserted-by":"crossref","unstructured":"Lan W, Petznick A, Heryati S, Rifada M, Tong L. Nuclear Factor-kappaB: central regulator in ocular surface inflammation and diseases. Ocul Surf. 2012; 10: 137\u2013148.","DOI":"10.1016\/j.jtos.2012.04.001"},{"key":"i1552-5783-59-8-3375-b20","doi-asserted-by":"crossref","unstructured":"Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004; 45: 4293\u20134301.","DOI":"10.1167\/iovs.03-1145"},{"key":"i1552-5783-59-8-3375-b21","doi-asserted-by":"crossref","unstructured":"Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017; 15: 276\u2013283.","DOI":"10.1016\/j.jtos.2017.05.008"},{"key":"i1552-5783-59-8-3375-b22","doi-asserted-by":"crossref","unstructured":"Zhang X, VJ, M Qu Y, et al. Dry eye management: targeting the ocular surface microenvironment. Int J Mol Sci. 2017; 18.","DOI":"10.3390\/ijms18071398"},{"key":"i1552-5783-59-8-3375-b23","doi-asserted-by":"crossref","unstructured":"Pflugfelder SC, de Paiva CS, Li DQ, Stern ME. Epithelial-immune cell interaction in dry eye. Cornea. 2008; 27 (suppl 1): S9\u2013S11.","DOI":"10.1097\/ICO.0b013e31817f4075"},{"key":"i1552-5783-59-8-3375-b24","doi-asserted-by":"crossref","unstructured":"Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012; 130: 90\u2013100.","DOI":"10.1001\/archophthalmol.2011.364"},{"key":"i1552-5783-59-8-3375-b25","doi-asserted-by":"crossref","unstructured":"Pflugfelder SC, Corrales RM, de Paiva CS. T helper cytokines in dry eye disease. Exp Eye Res. 2013; 117: 118\u2013125.","DOI":"10.1016\/j.exer.2013.08.013"},{"key":"i1552-5783-59-8-3375-b26","doi-asserted-by":"crossref","unstructured":"Liu Y, Liu Y, Xu D, Li J. Latanoprost-induced cytokine and chemokine release from human tenon's capsule fibroblasts: role of MAPK and NF-kappaB signaling pathways. J Glaucoma. 2015; 24: 635\u2013641.","DOI":"10.1097\/IJG.0000000000000140"},{"key":"i1552-5783-59-8-3375-b27","doi-asserted-by":"crossref","unstructured":"De Paiva CS, Chotikavanich S, Pangelinan SB, et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. 2009; 2: 243\u2013253.","DOI":"10.1038\/mi.2009.5"},{"key":"i1552-5783-59-8-3375-b28","doi-asserted-by":"crossref","unstructured":"Kimura K, Morita Y, Orita T, Haruta J, Takeji Y, Sonoda KH. Protection of human corneal epithelial cells from TNF-alpha-induced disruption of barrier function by rebamipide. Invest Ophthalmol Vis Sci. 2013; 54: 2572\u20132760.","DOI":"10.1167\/iovs.12-11294"},{"key":"i1552-5783-59-8-3375-b29","doi-asserted-by":"crossref","unstructured":"Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol. 2005; 166: 409\u2013419.","DOI":"10.1016\/S0002-9440(10)62264-X"},{"key":"i1552-5783-59-8-3375-b30","doi-asserted-by":"crossref","unstructured":"Lee SY, Jeong JJ, Le TH, et al. Ocotillol, a majonoside R2 metabolite, ameliorates 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice by restoring the balance of Th17\/treg cells. J Agric Food Chem. 2015; 63: 7024\u20137031.","DOI":"10.1021\/acs.jafc.5b02183"},{"key":"i1552-5783-59-8-3375-b31","doi-asserted-by":"crossref","unstructured":"Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci. 2003; 44: 124\u2013129.","DOI":"10.1167\/iovs.02-0581"},{"key":"i1552-5783-59-8-3375-b32","unstructured":"Mohan RR, Mohan RR, Kim WJ, Wilson SE. Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB. Invest Ophthalmol Vis Sci. 2000; 41: 1327\u20131336."},{"key":"i1552-5783-59-8-3375-b33","doi-asserted-by":"crossref","unstructured":"Zhang X, Chen W, De Paiva CS, et al. Desiccating stress induces CD4+ T-cell-mediated Sjogren's syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-gamma. Am J Pathol. 2011; 179: 1807\u20131814.","DOI":"10.1016\/j.ajpath.2011.06.030"},{"key":"i1552-5783-59-8-3375-b34","doi-asserted-by":"crossref","unstructured":"De Paiva CS, Raince JK, McClellan AJ, et al. Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol. 2011; 4: 397\u2013408.","DOI":"10.1038\/mi.2010.82"},{"key":"i1552-5783-59-8-3375-b35","doi-asserted-by":"crossref","unstructured":"De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci. 2007; 48: 2553\u20132560.","DOI":"10.1167\/iovs.07-0069"},{"key":"i1552-5783-59-8-3375-b36","doi-asserted-by":"crossref","unstructured":"Doucette LP, Walter MA. Prostaglandins in the eye: function, expression, and roles in glaucoma. Ophthalmic Genet. 2017; 38: 108\u2013116.","DOI":"10.3109\/13816810.2016.1164193"},{"key":"i1552-5783-59-8-3375-b37","unstructured":"Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997; 38: 2772\u20132780."},{"key":"i1552-5783-59-8-3375-b38","doi-asserted-by":"crossref","unstructured":"Honda N, Miyai T, Nejima R, et al. Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface. Arch Ophthalmol. 2010; 128: 466\u2013471.","DOI":"10.1001\/archophthalmol.2010.40"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2687704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:55Z","timestamp":1791927055000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,10]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,7,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24013","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,10]]}}}